BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20082634)

  • 1. Alternative splicing: regulation of HIV-1 multiplication as a target for therapeutic action.
    Tazi J; Bakkour N; Marchand V; Ayadi L; Aboufirassi A; Branlant C
    FEBS J; 2010 Feb; 277(4):867-76. PubMed ID: 20082634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication.
    Stoltzfus CM
    Adv Virus Res; 2009; 74():1-40. PubMed ID: 19698894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
    Malim MH; Hauber J; Le SY; Maizel JV; Cullen BR
    Nature; 1989 Mar; 338(6212):254-7. PubMed ID: 2784194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiviral strategies in the replication of human immunodeficiency virus].
    Wainberg MA; Bour S; Geleziunas R; Bentwich Z
    Union Med Can; 1992; 121(5):307-9, 312-4. PubMed ID: 1279875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of HIV-1 replication by RNA interference.
    Lee NS; Rossi JJ
    Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 reverse transcription initiation: a potential target for novel antivirals?
    Abbink TE; Berkhout B
    Virus Res; 2008 Jun; 134(1-2):4-18. PubMed ID: 18255184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral dynamics in human immunodeficiency virus type 1 infection.
    Wei X; Ghosh SK; Taylor ME; Johnson VA; Emini EA; Deutsch P; Lifson JD; Bonhoeffer S; Nowak MA; Hahn BH
    Nature; 1995 Jan; 373(6510):117-22. PubMed ID: 7529365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences.
    Gorelick RJ; Gagliardi TD; Bosche WJ; Wiltrout TA; Coren LV; Chabot DJ; Lifson JD; Henderson LE; Arthur LO
    Virology; 1999 Mar; 256(1):92-104. PubMed ID: 10087230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.
    O'Reilly MM; McNally MT; Beemon KL
    Virology; 1995 Nov; 213(2):373-85. PubMed ID: 7491762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico mutagenesis of RNA splicing in HIV-1.
    Kim H; Yin J
    Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
    Martinez-Picado J; Martínez MA
    Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
    Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
    Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor.
    Abbink TE; Berkhout B
    J Virol; 2008 Mar; 82(6):3090-8. PubMed ID: 18160437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus.
    Aquaro S; Bagnarelli P; Guenci T; De Luca A; Clementi M; Balestra E; Caliò R; Perno CF
    J Med Virol; 2002 Dec; 68(4):479-88. PubMed ID: 12376954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ins and outs of HIV replication.
    Gomez C; Hope TJ
    Cell Microbiol; 2005 May; 7(5):621-6. PubMed ID: 15839891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.